Thålin C

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C

J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution

Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2

Roxhed N, Bendes A, Dale M, ..., Fredolini C, Schwenk JM

Nat Commun 12 (1) - [2021-12-00; online 2021-06-17]

Category: Health Category: Serology Funder: H2020 Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2

Havervall S, Marking U, Greilert-Norin N, ..., Åberg M, Thålin C

EBioMedicine 70 (-) 103523 [2021-08-00; online 2021-08-00]

Category: Drug Discovery Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article

Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.

Ng H, Havervall S, Rosell A, ..., Thålin C, Phillipson M

Arterioscler Thromb Vasc Biol 41 (2) 988-994 [2021-02-00; online 2020-12-03]

Category: Health Funder: KAW/SciLifeLab Funder: VR Research Area: Biobanks for COVID-19 research Type: Journal article